Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

Objective To study the effectiveness and safety of the non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) dabigatran, rivaroxaban, and apixaban compared with warfarin in anticoagulant naïve patients with atrial fibrillation. Design Observational nationwide cohort study....

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Torben Bjerregaard, Skjøth, Flemming, Nielsen, Peter Brønnum, Kjældgaard, Jette Nordstrøm, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910696/
https://www.ncbi.nlm.nih.gov/pubmed/27312796
http://dx.doi.org/10.1136/bmj.i3189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910696/
https://www.ncbi.nlm.nih.gov/pubmed/27312796
http://dx.doi.org/10.1136/bmj.i3189

Ejemplares similares